Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

10drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Inavolisib ×

Inavolisib

This drug is selected. Its supporting articles are shown below.

Inavolisib2

Articles mentioning Inavolisib

2 articles · page 1 of 1

4CPS-097 AUC based method to estimate overall survival benefit of inavolisib + palbociclib + fulvestrant versus palbociclib + fulvestrant

ejhpharm · abstract · 2026-03-18 · 6 matching annotations

98.4%

inavolisib palbociclib fulvestrant palbociclib-fulvestrant pomalidomide adjuvant endocrine therapy breast cancer

…eting adjuvant endocrine therapy.In the pivotal INAVO120 trial, inavolisib demonstrated a benefit over palbociclib-fulvestrant, with a med…

Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging

bmjonc · full text · 2026-04-07 · 4 matching annotations

92.0%

Zykadia Cyramza Fruzaqla Fruquintinib Imfinzi durvalumab ramucirumab Brigatinib ceritinib

…), atezolizumab (Tecentriq), osimertinib (Tagrisso), ceritinib (Zykadia) and nintedanib (Vargatef). EMA labels for all products include…